Potential uses of intravenous proton pump inhibitors to control gastric acid secretion

被引:23
作者
Metz, DC [1 ]
机构
[1] Univ Penn, Div Gastroenterol, Hlth Syst, Philadelphia, PA 19104 USA
关键词
histamine H-2-receptor antagonists; pantoprazole; ulcer prophylaxis; gastroesophageal reflux disease; gastrointestinal bleeding; intravenous administration;
D O I
10.1159/000007798
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Proton pump inhibitors are the most effective agents for suppressing gastric acidity and are the preferred therapy for many acid-related conditions. While proton pump inhibitors have been accessible in intravenous formulations in several European countries, they have been available only as oral drugs in the United States. In the near future, the proton pump inhibitor pantoprazole is likely to become available in an intravenous formulation for American patients. Potential uses for intravenous proton pump inhibitors include treatment of Zollinger-Ellison syndrome and peptic ulcers complicated by bleeding or gastric outlet obstruction, as well as prevention of stress ulcers and acid-induced lung injury. These intravenous proton pump inhibitors are also likely to be beneficial to patients undergoing long-term maintenance with oral proton pump inhibitors who cannot take oral therapy for a period of time. Intravenous pantoprazole is especially distinguished in its lack of clinically relevant drug interactions, and it requires no dosage adjustment for patients with renal insufficiency or with mild to moderate hepatic dysfunction, Both omeprazole and pantoprazole are well tolerated in both oral and intravenous forms. Although further studies are needed to define their roles clearly, the availability of intravenous formulations of proton pump inhibitors will certainly assist with the treatment of gastric acid-related disorders, Copyright (C) 2000 S. Karser AG. Basel.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 50 条
[41]   Proton Pump Inhibitors Improve Acid-Related Dyspepsia in Gastroesophageal Reflux Disease Patients [J].
Motoyasu Kusano ;
Yasuyuki Shimoyama ;
Osamu Kawamura ;
Masaki Maeda ;
Shikou Kuribayashi ;
Atsuto Nagoshi ;
Hiroaki Zai ;
Fumitaka Moki ;
Tsutomu Horikoshi ;
Munetoshi Toki ;
Sayaka Sugimoto ;
Masatomo Mori .
Digestive Diseases and Sciences, 2007, 52 :1673-1677
[42]   Can Nocturnal Acid-breakthrough Be Reduced by Long-acting Proton Pump Inhibitors? [J].
Jeon, Hye Kyung ;
Kim, Gwang Ha .
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 23 (02) :145-148
[43]   Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients [J].
Kusano, Motoyasu ;
Shimoyama, Yasuyuki ;
Kawamura, Osamu ;
Maeda, Masaki ;
Kuribayashi, Shikou ;
Nagoshi, Atsuto ;
Zai, Hiroaki ;
Moki, Fumitaka ;
Horikoshi, Tsutomu ;
Toki, Munetoshi ;
Sugimoto, Sayaka ;
Mori, Masatomo .
DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (07) :1673-1677
[44]   A false sense of security; symptom control does not predict healing of oesophagitis on proton pump inhibitors [J].
Tan, V. P. Y. ;
Wong, B. C. Y. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (03) :307-308
[45]   Perceived risk of gastric cancer associated with long-term use of proton pump inhibitors: Bridging the gap [J].
Sawaied, Ibrahim O. ;
Samson, Abraham O. ;
Golan, Efrat .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2025, 16 (07)
[46]   Reducing gastric secretions-a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction? [J].
Clark, K. ;
Lam, L. ;
Currow, D. .
SUPPORTIVE CARE IN CANCER, 2009, 17 (12) :1463-1468
[47]   Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding [J].
Gagnon, YM ;
Levy, AR ;
Eloubeidi, MA ;
Arguedas, MR ;
Rioux, KP ;
Enns, RA .
VALUE IN HEALTH, 2003, 6 (04) :457-465
[48]   Inappropriate utilization of intravenous proton pump inhibitors in hospital practice-a prospective study of the extent of the problem and predictive factors [J].
Craig, D. G. N. ;
Thimappa, R. ;
Anand, V. ;
Sebastian, S. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (05) :327-335
[49]   Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: A multicentre comparative study [J].
Andrews, CN ;
Levy, A ;
Fishman, M ;
Hahn, M ;
Atkinson, K ;
Kwan, P ;
Enns, R .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (11) :667-671
[50]   Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-analysis [J].
Peng, Carol Chiung-Hui ;
Tu, Yu-Kang ;
Lee, Gin Yi ;
Chang, Rachel Huai-En ;
Huang, Yuting ;
Bukhari, Khulood ;
Tsai, Yao-Chou ;
Fu, Yunting ;
Huang, Huei-Kai ;
Munir, Kashif M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (11) :3354-3366